• Health & Medicine

US lung cancer data points to the power of cancer research

New data suggest that targeted therapy seems to be having an impact on the treatment of lung cancer. New data suggest that targeted therapy seems to be having an impact on the treatment of lung cancer.

18 August 2020

• Health & Medicine

Are differences in treatment driving variation in ovarian cancer survival internationally?

The latest ovarian cancer data from the ICBP reveals that while more people are surviving their cancer, there’s still a long way to go. The latest ovarian cancer data from the ICBP reveals that while more people are surviving their cancer, there’s still a long way to go.

11 August 2020

• Science & Technology

Cytosponge: A ‘sponge on a string' test to detect oesophageal cancer earlier

Looking at the latest results from the BEST3 trial, analysing the ‘sponge-on-a-string' test to detect oesophageal cancer earlier. Looking at the latest results from the BEST3 trial, analysing the ‘sponge-on-a-string' test to detect oesophageal cancer earlier.

31 July 2020

• Health & Medicine

UK public urged to take care this summer as around 40% spending more time in the sun since COVID-19 lockdown

New figures from Cancer Research UK and NIVEA SUN suggest that people are not protecting themselves properly from the sun in the UK. New figures from Cancer Research UK and NIVEA SUN suggest that people are not protecting themselves properly from the sun in the UK.

22 July 2020

• Health & Medicine

44% rise in patients waiting for tests to diagnose bowel, stomach, bladder and oesophageal cancer

55,500 more people are waiting to get tests used to diagnose four common cancers compared to last year. 55,500 more people are waiting to get tests used to diagnose four common cancers compared to last year.

20 July 2020

• Health & Medicine

Targeted treatment for leukaemia approved on NHS in England 

The targeted drug gilteritinib is now recommended for some adults with acute myeloid leukaemia (AML) on the NHS in England.   The targeted drug gilteritinib is now recommended for some adults with acute myeloid leukaemia (AML) on the NHS in England.  

16 July 2020

• Health & Medicine

Pursuing precision medicine in a flagship lung cancer trial

The National Lung Matrix Trial - a £25 million collaboration with pharmaceutical companies and the NHS - has been exploring how patients with non small cell lung cancer respond to more tailored, targeted treatments. The National Lung Matrix Trial - a £25 million collaboration with pharmaceutical companies and the NHS - has been exploring how patients with non small cell lung cancer respond to more tailored, targeted treatments.

15 July 2020

• Health & Medicine

New treatment for rare blood cancer approved for NHS use in England

The National Institute for Health and Care Excellence (NICE) has approved the drug brentuximab vedotin on the NHS in England. The National Institute for Health and Care Excellence (NICE) has approved the drug brentuximab vedotin on the NHS in England.

10 July 2020

• Health & Medicine
• Policy & Insight

Urgent cancer referrals being turned down during coronavirus pandemic 

Around a quarter of GPs have said that urgent referrals for suspected cancer had been turned down by hospitals more often than before the pandemic. Around a quarter of GPs have said that urgent referrals for suspected cancer had been turned down by hospitals more often than before the pandemic.

8 July 2020

• Health & Medicine

Scotland's lifeline cancer trials must be restarted urgently

Cancer Research UK’s calls backed by eminent Edinburgh scientist who says the COVID-19 halt to clinical trials has taken away hope for some patients. Cancer Research UK’s calls backed by eminent Edinburgh scientist who says the COVID-19 halt to clinical trials has taken away hope for some patients.

29 June 2020

• Health & Medicine

Prostate cancer hormone therapy not recommended for NHS in England

A hormone therapy has been rejected for some adults with newly-diagnosed, advanced prostate cancer. A hormone therapy has been rejected for some adults with newly-diagnosed, advanced prostate cancer.

26 June 2020

• Health & Medicine

Targeted drug improves survival for children with non-Hodgkin lymphoma

New clinical trial results show that adding rituximab to standard chemotherapy could improve survival for some children with non-Hodgkin lymphoma. New clinical trial results show that adding rituximab to standard chemotherapy could improve survival for some children with non-Hodgkin lymphoma.

25 June 2020